|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.700 SEK | +2.53% |
|
0.00% | +315.65% |
| 11:51am | Medivir Receives Notice of Allowance for Fostrox Plus Lenvatinib Combination Patent in the Usa | CI |
| 05:27am | Medivir Gets Allowance Notice From US Patent Office for Liver Cancer Treatment | MT |
| Market Cap | 1.02B 106M 92.7M 85.68M 78.8M 149M 10.2B 151M 402M 4.99B 397M 388M 17.19B | P/E 2026 * |
-10.9x | P/E 2027 * | -7.59x |
|---|---|---|---|---|---|
| Enterprise Value | 929M 95.85M 84.01M 77.65M 71.42M 135M 9.24B 137M 364M 4.52B 360M 352M 15.58B | EV / Sales 2026 * |
155x | EV / Sales 2027 * | 6.09x |
| Free-Float |
69.52% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Medivir AB
| 1 day | +3.38% | ||
| Current month | -3.85% | ||
| 1 month | +1.19% | ||
| 3 months | -10.62% | ||
| 6 months | +240.00% | ||
| Current year | +315.65% |
| 1 week | 1.64 |  | 1.8 |
| 1 month | 1.6 | | 1.88 |
| Current year | 0.39 | | 2.88 |
| 1 year | 0.34 | | 2.88 |
| 3 years | 0.34 | | 8.58 |
| 5 years | 0.34 | | 11.84 |
| 10 years | 0.34 | | 102 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jens Lindberg
CEO | Chief Executive Officer | 55 | 2022-01-23 |
Patrik Norgren
DFI | Director of Finance/CFO | - | 2026-03-22 |
Pia Baumann
CTO | Chief Tech/Sci/R&D Officer | 60 | 2023-02-19 |
| Director | Title | Age | Since |
|---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 76 | 2021-05-04 |
| Director/Board Member | 70 | 2018-05-02 | |
Yilmaz Mahshid
BRD | Director/Board Member | 47 | 2021-05-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/18/26 | Buy | 144,508 | 0.0268% | |||
| 6/18/26 | Buy | Chief Financial Officer | 18,000 | 0.0033% | ||
| 12/5/25 | Buy | 90,000 | 0.0802% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.53% | 0.00% | -15.00% | -76.15% | 106M | |
| +0.21% | -0.79% | +56.02% | +57.39% | 53.83B | |
| +5.37% | +0.75% | +50.39% | +83.03% | 52.1B | |
| -0.36% | -0.62% | +5.53% | +409.46% | 23.48B | |
| +0.30% | +2.20% | -15.48% | -14.55% | 23.13B | |
| +3.46% | +0.79% | +34.01% | -4.47% | 19.36B | |
| -1.18% | -2.97% | +32.73% | -33.30% | 17.56B | |
| -1.67% | -8.56% | +163.95% | +284.69% | 15.2B | |
| +3.62% | -2.42% | +29.70% | +663.64% | 14.83B | |
| -0.28% | +0.36% | +27.07% | +183.04% | 14.06B | |
| Average | +1.47% | -2.64% | +36.89% | +155.28% | 23.37B | |
| Weighted average by Cap. | +1.70% | -2.35% | +42.62% | +140.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.98M 617K 541K 500K 460K 868K 59.51M 882K 2.34M 29.12M 2.32M 2.27M 100M | 144M 14.91M 13.07M 12.08M 11.11M 20.96M 1.44B 21.3M 56.62M 703M 55.98M 54.76M 2.42B |
| Net income | -77.84M -8.04M -7.04M -6.51M -5.99M -11.3M -775M -11.48M -30.51M -379M -30.17M -29.51M -1.31B | 33.13M 3.42M 3M 2.77M 2.55M 4.81M 330M 4.89M 12.99M 161M 12.84M 12.56M 556M |
| Net Debt | -96M -9.91M -8.69M -8.03M -7.38M -13.93M -956M -14.16M -37.63M -468M -37.21M -36.4M -1.61B | -145M -14.97M -13.12M -12.13M -11.15M -21.04M -1.44B -21.38M -56.84M -706M -56.2M -54.98M -2.43B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | SEK 1.700 | +2.53% | 2,333,578 |
| 26-07-17 | SEK 1.658 | -4.60% | 1,902,505 |
| 26-07-16 | SEK 1.738 | -0.46% | 968,668 |
| 26-07-15 | SEK 1.746 | +1.04% | 1,319,586 |
| 26-07-14 | SEK 1.728 | +1.65% | 588,518 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MVIR B Stock
Select your edition
All financial news and data tailored to specific country editions
